Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom-Reference-Cited by-同舟云学术

Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom

Published:2017-01-20 Issue:4 Volume:31 Page:650-656
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Alfaqawi F,Lip P L,Elsherbiny S,Chavan R,Mitra A,Mushtaq B

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye2016301.pdf

Reference28 articles.

1. Moss SE, Klein R, Klein BE . Ten-year incidence of visual loss in a diabetic population. Ophthalmology 1994; 101: 1061–1070.

2. Klein R, Lee KE, Gangnon RE, Klein BE . The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology 2010; 117: 63–70.

3. Antonetti DA, Lieth E, Barber AJ, Gardner TW . Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 1999; 14: 240–248.

4. Klaassen I, Van Noorden CJ, Schlingemann RO . Molecular basis of the inner blood–retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res 2013; 34: 19–48.

5. Ehrlich R, Harris A, Ciulla TA, Kheradiya N, Winston DM, Wirostko B . Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process. Acta Ophthalmol 2010; 88: 279–291.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study;Clinical Ophthalmology;2024-04

2. Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data;European Journal of Ophthalmology;2024-03-11

3. Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study;International Ophthalmology;2023-09-12

4. Suboptimal outcomes and treatment burden of anti-vascular endothelial growth factor treatment for diabetic macular oedema in phakic patients;Eye;2023-08-04

5. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-07-11